Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

Allosteric Modulation and Accelerated Resensitization of Human P2X3 Receptors by Cibacron Blue

Karen Alexander, Wende Niforatos, Bruce Bianchi, Edward C. Burgard, Kevin J. Lynch, Elizabeth A. Kowaluk, Michael F. Jarvis and Tim van Biesen
Journal of Pharmacology and Experimental Therapeutics December 1999, 291 (3) 1135-1142;
Karen Alexander
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wende Niforatos
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruce Bianchi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward C. Burgard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin J. Lynch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth A. Kowaluk
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael F. Jarvis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tim van Biesen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The activity of ATP as a fast neurotransmitter is mediated by the P2X family of ligand-gated ion channels. P2X receptor subtypes are subject to functional modulation by a diverse set of factors, including pH, divalent cations, and temperature. The human P2X3(hP2X3) receptor subunit is expressed primarily in sensory ganglia where it exists as either a homomultimeric receptor or, in combination with P2X2, as a heteromultimeric receptor. This article describes the allosteric modulatory effect of the putative P2X receptor antagonist cibacron blue on the activity of recombinant hP2X3 receptors. In 1321N1 cells expressing the hP2X3 receptor, cibacron blue mediated a 3- to 7-fold increase in both the magnitude and the potency of ATP-activated Ca2+ influx and transmembrane currents. The half-maximal concentration of cibacron blue required to mediate maximal potentiation (EC50 = 1.4 μM) was independent of the agonist used to activate the hP2X3 receptor. The nonselective P2 receptor antagonist PPADS (pyridoxal-5-phosphate-6-azophenyl-2′,4′-disulfonic acid) caused a rightward shift of the cibacron blue concentration-effect curve, whereas increasing concentrations of cibacron blue attenuated PPADS antagonism. In addition to potentiating the effects of ATP at the hP2X3 receptor, cibacron blue also produced a 6-fold increase in the rate of hP2X3receptor recovery from desensitization (from T1/2 = 15.9 to 2.6 min), as evidenced by its ability to restore ATP responsiveness to acutely desensitized receptors. Consistent with the properties of other ligand-gated ion channels, these results suggest that hP2X3 receptor activity can be allosterically modulated by a ligand distinct from the endogenous agonist.

Footnotes

  • Send reprint requests to: Tim van Biesen, Ph.D., Neurological and Urological Diseases Research, D-4PM, AP9A, Abbott Laboratories, Abbott Park, IL 60064-3500. E-mail:tim.vanbiesen{at}abbott.com

  • Abbreviations:
    2-meSATP
    2-methylthio-ATP tetrasodium
    αβ-meATP
    αβ-methylene ATP dilithium
    BzATP
    2′- and 3′-O-(4-benzoylbenzoyl)-ATP tetraethylammonium salt
    PPADS
    pyridoxal-5-phosphate-6-azophenyl-2′,4′-disulfonic acid
    • Received April 27, 1999.
    • Accepted August 17, 1999.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 291 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 291, Issue 3
1 Dec 1999
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Allosteric Modulation and Accelerated Resensitization of Human P2X3 Receptors by Cibacron Blue
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Allosteric Modulation and Accelerated Resensitization of Human P2X3 Receptors by Cibacron Blue

Karen Alexander, Wende Niforatos, Bruce Bianchi, Edward C. Burgard, Kevin J. Lynch, Elizabeth A. Kowaluk, Michael F. Jarvis and Tim van Biesen
Journal of Pharmacology and Experimental Therapeutics December 1, 1999, 291 (3) 1135-1142;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Allosteric Modulation and Accelerated Resensitization of Human P2X3 Receptors by Cibacron Blue

Karen Alexander, Wende Niforatos, Bruce Bianchi, Edward C. Burgard, Kevin J. Lynch, Elizabeth A. Kowaluk, Michael F. Jarvis and Tim van Biesen
Journal of Pharmacology and Experimental Therapeutics December 1, 1999, 291 (3) 1135-1142;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Experimental Procedures
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PST3093 Stimulates SERCA2a and Improves Cardiac Function
  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Discriminative Stimulus Effects of Zolpidem in Squirrel Monkeys: Comparison with Conventional Benzodiazepines and Sedative-Hypnotics
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics